Application of IELLQAR as medicine for preventing and treating atherosclerosis diseases
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- FIRST AFFILIATED HOSPITAL OF DALIAN MEDICAL UNIV
- Publication Date
- 2019-01-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of medicine, and IELLQAR is used as a medicine for preventing and treating atherosclerosis-related diseases. Background technique
[0002] Myocardial infarction is one of the main causes of death that threatens human health, and has the characteristics of high morbidity and mortality. Although the number of new technologies represented by percutaneous coronary intervention technology continues to increase, the prevalence and mortality of myocardial infarction in China have not declined in the past decade. Therefore, it is crucial to discover the early pathogenesis of myocardial infarction and prevent and treat it. important. Atherosclerosis is an important pathological mechanism in the occurrence of myocardial infarction, and its pathogenesis has not been fully elucidated. In recent years, more and more studies have shown that atherosclerosis is a chronic inflammatory disease, and immune cells and inflammat...